Summary Sialyl-Tn (STn) is a carcinoma-associated carbohydrate determinant expressed on cancer-associated mucins and has the structure NANAa(2-6)aGalNAc. Expression of STn in colon and ovarian cancer is associated with a poor prognosis independent of tumour grade, stage or histological type. We have examined 237 cases of primary breast cancer for expression of this antigen using the antibody HB-STn (Dako). The frequency of STn expression was 31% in the whole group, 36% in the node-negative and 28% in the node-positive group. Survival was lower, but not significantly so, in the STn-positive group (P = 0.07), but this effect was highly significant for patients with node-positive disease (P<0.002), the curves for node-negative disease being coincident (P= 0.31). In node-positive disease the effect was limited to those receiving adjuvant chemotherapy (P = 0.001). In a multivariate (Cox) analysis on the whole group STn staining, combined with adjuvant chemotherapy, showed a highly significant correlation with survival. In STn-negative cases, adjuvant chemotherapy improved survival (relative risk 2.3, 95% confidence intervals 1.4-3.9), whereas adjuvant chemotherapy did not influence survival in patients which expressed STn (relative risk 1.1, 95% confidence intervals 0.6-2.2). Thus, by either direct or indirect mechanisms, STn positivity appears to be a marker of resistance to adjuvant chemotherapy.
Abnormal glycosylation patterns have been recognised as a feature of carcinoma-associated mucins (Hakomori, 1985) . Expression of blood group-related carbohydrate antigens demonstrated by lectin binding (Fenlon et al., 1987; Leathem & Brooks, 1987) and monoclonal antibodies (Narita et al., 1993) has been shown to be of prognostic importance in primary breast cancer. One potential mechanism to explain this finding is that blood group-related antigens such as sialyl-Lea and sialyl Lex are known to be ligands for the endothelial cell adhesion molecule ELAM-l/E-selectin (Lowe et al., 1990; Takada et al., 1991) , which may therefore result in an increase in the metastatic potential of malignant cells expressing these antigens.
Sialyl-Tn [a(2-6)-N-acetylgalactosamine, STn] is a core region carbohydrate antigen of tumour-associated mucin (Kjeldsen et al., 1988) formed by the premature 2-6 sialation of N-acetylgalactosamine (Nakasaki et al., 1989) . STn expression has been studied in several tumour types and found to be of prognostic significance in colonic (Itzkowitz et al., 1990) and gastric carcinoma (Chun Ma et al., 1993) . Circulating antigen has been detected in gastrointestinal and ovarian malignancies, and raised levels have also been shown to be associated with a poor prognosis (Motoo et al., 1991; Kobayashi et al., 1992) .
The incidence of expression of STn in primary breast cancer has been reported previously and is less than that observed in gastrointestinal and ovarian malignancies (Yonezawa et al., 1992) . In this study we have examined the prognostic significance of STn expression in primary breast cancer. (Howell et al., 1984) . During this period patients with node-negative disease were not routinely given chemotherapy, although one patient in this group did receive adjuvant CMF. Tumour size measured clinically was recorded in 234 cases. Steroid hormone receptor status was determined using a dextran-coated ligand binding assay (King et al., 1979) Statistical analysis Relationships between variables were examined using the chi-squared and Mann-Whitney tests. Relapse-free and overall survival were calculated using the method of Kaplan and Meier (Peto et al., 1977) , and differences between curves were analysed by the log-rank test. Multivariate analysis was by Cox's proportional hazards model (Cox, 1972 Table I , none being statistically significant.
Patients and methods

Patients
Although patients with STn-positive tumours had a lower survival, this was not significant (P = 0.07, Figure 2 ). The influence of STn positivity on survival was then examined within subgroups defined by nodal status. STn positivity did not influence survival in patients with node-negative breast cancer (P = 0.31, Figure 3 ) but in the node-positive group those patients which were also STn positive had a shorter survival than those with STn-negative tumours (P<0.001, Figure 3 ). STn positivity was not of prognostic significance in patients with node-positive disease who did not receive adjuvant chemotherapy (P = 0.24, Figure 4 ), but was in those so treated (P = 0.001, Figure 4 ). Established prognostic factors were well balanced in the two arms of the adjuvant chemotherapy study (data previously published). There was no imbalance of prognostic factors between STn-positive and-negative patients who received adjuvant chemotherapy.
In univariate analyses, nodal status was the most powerful predictor of relapse-free (P<0.0001, Table II Table II ). In terms of overall survival, adjuvant chemotherapy and STn negativity remained an independent prognostic factor (X2 = 11.79, P = 0.0006; Table III ). Administration of adjuvant chemotherapy in patients with nodepositive disease whose tumours were STn negative was associated with improved survival [relative risk 2.3, 95% confidence intervals (CI) 1.4-3.9]. Conversely, the use of adjuvant chemotherapy for node-positive and STn-positive tumours did not improve survival (relative risk 1.1, 95% CI 0.6-2.2).
Discussion
Malignant transformation of epithelial cells is frequently associated with altered glycosylation of cell membrane glycoproteins or glycolipids. In the case of 0-linked oligosaccharides, the premature 2-6 sialation of the Tn antigen (GalNAc) leads to accumulation of the STn antigen (Nakasaki et al., 1989) . Expression of this carcinoma-associated antigen sialyl Tn has been shown to be a prognostic factor in ovarian, gastric and colorectal adenocarcinomas. It has been demonstrated that normal glycoproteins (Simon et al., 1990) , tumour-associated glycoproteins (Irimura et al., 1987) and sialic acid residues (Dennis et al., 1982) Although STn positivity may reflect aberrant glycosylation of other peptides, the function of P-glycoprotein, associated with multidrug resistance, is not influenced by its degree of glycosylation (Beck & Cirtain, 1982; Ling et al., 1983) . Proposed mechanisms of drug resistance are based largely on unicellular characteristics involving reduced drug uptake, increased drug efflux, increased drug inactivation, increased DNA repair and altered molecular expression of drug targets within cells. Other evidence showing that tumour cells grown in monolayer culture may be more sensitive to cytotoxic drugs than when grown as multicellular spheroids (Sutherland, 1988) , suggests that some forms of drug resistance operate at a multicellular level. Altered cell-cell interactions as a result of aberrant carbohydrate expression may be important in mediating this type of drug resistance.
